Accel Research Sites Network acquires 2 new locations

Clinical trial leader will now serve Ormond Beach, Edgewater in Florida

ORLANDO, Fla.–(BUSINESS WIRE)–Accel Research Sites Network has always been dedicated to bringing innovative treatments to a variety of patients through cutting-edge clinical trials. The company will now be able to serve an even larger population, expanding its community reach.

The clinical trial leader announced the acquisition of two new site locations in Ormond Beach, Fla., and Edgewater, Fla, bringing the company’s total number of sites to 25. The sites—Ormond Medical Arts (OMA)-Pharmaceutical Research Center, formerly Complete Health Research—will now be known as Accel Research Sites Ormond Beach and Accel Research Sites Edgewater.

“Our mission and vision centers around patients, partners and people,” said Lora Parahovnik, CEO of Accel Research Sites. “We are thrilled that the addition of these sites means we will be able to work with outstanding providers, deepen our already talented team, and most importantly, reach even more patients in communities who can benefit from innovative treatment and research.”

The new sites have expertise in clinical trials for women’s health, migraine, dermatology, osteoarthritis, blood/specimen collections, pulmonology, diabetes, hypertension, and hyperlipidemia. Both sites have access to a local lab and two area imaging facilities for CT, DEXA, mammogram, ultrasounds and X-rays. The Edgewater location also has capabilities for infusions.

The acquisition also means the addition of six experienced principal investigators to the Accel team, as well as clinical staff members.

Both sites are strategically placed in the greater Central Florida area close enough to be supported by Accel’s central functions, but still mean Accel will have the chance to serve expanded patient populations in Florida. The Edgewater site, particularly, is strategically placed to provide exciting treatment options to a community that might not otherwise have access.

Over Parahovnik’s tenure, the company has tripled its locations, servicing an area of Florida across the I-4 corridor, as well as offering several locations in the Birmingham, Ala., and Atlanta, Ga., areas.

For more information, visit accelresearchsites.com.

About Accel Research Sites Network

Accel Research Sites Network is a multi-therapeutic network of clinical research sites dedicated to the expert delivery of treatment options to patients and providers. They partner with the most innovative and significant pharmaceutical, biotechnology, and medical device companies worldwide to advance healthcare and wellness in the communities they serve.

Contacts

Will Wellons

Wellons Communications

407-462-2718

[email protected]

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.